Urgent need to address the slow scale-up of TB preventive treatment in the WHO South-East Asia Region.
Int J Tuberc Lung Dis
; 25(5): 382-387, 2021 05 01.
Article
in English
| MEDLINE | ID: covidwho-1502726
ABSTRACT
In September 2018, all countries made a commitment at the first ever United Nations High-Level Meeting (UNHLM) on TB, to provide TB preventive treatment (TPT) to at least 30 million people at high-risk of TB disease between 2018 and 2022. In the WHO South-East Asia Region (SEA Region), which accounts for 44% of the global TB burden, only 1.2 million high-risk individuals (household contacts and people living with HIV) were provided TPT (11% of the 10.8 million regional UNHLM TPT target) in 2018 and 2019. By 2020, almost all 11 countries of the SEA Region had revised their policies on TPT target groups and criteria to assess TPT eligibility, and had adopted at least one shorter TPT regimen recommended in the latest WHO TPT guidelines. The major challenges for TPT scale-up in the SEA Region are resource shortages, knowledge and service delivery/uptake gaps among providers and service recipients, and the lack of adequate quantities of rifapentine for use in shorter TPT regimens. There are several regional opportunities to address these gaps and countries of the SEA Region must make use of these opportunities to scale up TPT services rapidly to reduce the TB burden in the SEA Region.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Tuberculosis
Type of study:
Experimental Studies
/
Observational study
/
Prognostic study
/
Randomized controlled trials
Limits:
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Int J Tuberc Lung Dis
Year:
2021
Document Type:
Article
Affiliation country:
Ijtld.20.0941
Similar
MEDLINE
...
LILACS
LIS